Vascular endothelial growth factor (VEGF) proteins stimulate vasculogenesis and angiogenesis. They are part of the system that restores the oxygen supply to tissues when blood circulation is inadequate. The normal function of VEGF proteins is to create new blood vessels during embryonic development, new blood vessels after injury, muscle following exercise, and new vessels (collateral circulation) to bypass blocked vessels. The VEGF family has six members, including VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and Placental Growth Factor (PGF). Activity of VEGF-A, as its name implies, has been studied mostly on cells of the vascular endothelium, although it does have effects on a number of other cell types (e.g., stimulation monocyte/macrophage migration, neurons, cancer cells, kidney epithelial cells). In vitro, VEGF-A has been shown to stimulate endothelial cell mitogenesis and cell migration. VEGF-A is also a vasodilator and increases microvascular permeability and was originally referred to as vascular permeability factor (VPF).
Reactivity - ELISA
Bovine VEGF-A - Weak
Canine VEGF-A - Weak
Equine VEGF-A - Strong
Mouse VEGF-A - Weak
Rat VEGF-A - Weak
Swine VEGF-A - Moderate
Equine VEGF-A ELISA Data
Effects of acellular equine amniotic allografts on the healing of experimentally induced full-thickness distal limb wounds in horses.
Fowler AW, Gilbertie JM, Watson VE, Prange T, Osborne JA, Schnabel LV.
Vet Surg. 2019 Nov;48(8):1416-1428. doi: 10.1111/vsu.13304. Epub 2019 Aug 6.
Applications: Measurement of Equine VEGF-A in supernatants by ELISA
Please note that Cookies and JavaScript are required for you to view this website.
Check if you have Cookies and JavaScript enabled in your browser